AstraZeneca PLCLondon, United Kingdom (NYSE: AZN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

AstraZeneca Financial Statements

AstraZeneca Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

AstraZeneca Income Statement

  2008 2007 2006
Revenue ($ mil.) 31,601.0 29,559.0 26,475.0
Gross Profit ($ mil.) 25,003.0 23,140.0 20,916.0
Operating Income ($ mil.) 9,998.0 9,053.0 9,104.0
Total Net Income ($ mil.) 6,130.0 5,595.0 6,043.0
Diluted EPS (Net Income) 4.20 14.92 3.85
More AstraZeneca financial information

AstraZeneca Stock Quote & Chart

11/09/09 16:02:25 EST • NYSE • 45.94 • Increased by +0.9600 • Increased by +2.1343 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

AstraZeneca Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.06 2.65 7.00
Price/Earnings Ratio 9.49 16.81 25.45
Price/Book Ratio 3.66 2.88 6.74
Price/Cash Flow Ratio 6.65 10.14 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed AstraZeneca Financial Ratios

AstraZeneca Competitive Intelligence

GlaxoSmithKline Merck Novartis
Annual Sales ($ mil.) 35,244.6 18,502.0 42,584.0
Employees 99,003 51,000 96,717
Market Cap ($ mil.) 114,528.4 46,142.1 119,419.7

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy